Global Tuberculosis Burden

A new Nature Medicine study examining TB data from 111 low‑ and middle‑income countries in 2023 concludes that misdiagnosis is far more common than previously appreciated, with roughly 1 million people who seek care for TB‑like symptoms each year actually having the disease but not being diagnosed, and more than 2 million others told they have TB when they do not. Co‑author Nicolas Menzies of the Harvard T.H. Chan School of Public Health says that means perhaps one in four people treated for tuberculosis worldwide may not in fact have TB, raising the risk that underlying illnesses such as pneumonia, lung cancer, or COPD go untreated. The analysis, which infers false positives and false negatives from WHO case reports, highlights heavy reliance on imperfect sputum‑based tests and on 'clinical diagnosis' from symptoms alone, particularly in resource‑poor settings where modern PCR testing is scarce. Outside experts are split: McGill’s Dr. Marcel Behr calls the work a rigorous and overdue look at false positives, while Stop TB Partnership head Dr. Lucica Ditiu warns it could be misused to cast doubt on TB statistics and discourage clinicians from diagnosing a disease that remains the world’s top infectious killer. For U.S. readers, the findings challenge long‑standing assumptions underlying global TB surveillance and funding, and they feed into wider debates about investing in better diagnostics, training, and quality control in programs that American taxpayers and institutions help finance.